|
1
|
Zhang SX, Qiu QH, Chen WB, Liang CH and
Huang B: Celecoxib enhances radiosensitivity via induction of
G2-M phase arrest and apoptosis in nasopharyngeal
carcinoma. Cell Physiol Biochem. 33:1484–1497. 2014. View Article : Google Scholar
|
|
2
|
Kamran SC, Riaz N and Lee N:
Nasopharyngeal carcinoma. Surg Oncol Clin N Am. 24:547–561. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu J, Zhao FP, Peng Z, Zhang MW, Lin SX,
Liang BJ, Zhang B, Liu X, Wang L, Li G, et al: EZH2 promotes
angiogenesis through inhibition of miR-1/Endothelin-1 axis in
nasopharyngeal carcinoma. Oncotarget. 5:11319–11332. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen LX, Zhu LY, Jacob TJ and Wang LW:
Roles of volume-activated Cl− currents and regulatory
volume decrease in the cell cycle and proliferation in
nasopharyngeal carcinoma cells. Cell Prolif. 40:253–267. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang
J, McCarthy JB, She X, Zhang W, Ma J, et al: miR-18a promotes
malignant progression by impairing microRNA biogenesis in
nasopharyngeal carcinoma. Carcinogenesis. 34:415–425. 2013.
View Article : Google Scholar
|
|
6
|
Zhang T, Sun Q, Liu T, Chen J, Du S, Ren
C, Liao G and Yuan Y: MiR-451 increases radiosensitivity of
nasopharyngeal carcinoma cells by targeting ras-related protein 14
(RAB14). Tumour Biol. 35:12593–12599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang GL, Chen ML, Li YZ, Lu Y, Pu XX, He
YX, Tang SY, Che H, Zou Y, Ding C, et al: Association of miR-146a
gene polymorphism with risk of nasopharyngeal carcinoma in the
central-southern Chinese population. J Hum Genet. 59:141–144. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang GL, Lu Y, Pu XX, He YX, Chen ML, Li
YZ, Tang SY, Che H and He Z: Association study between miR-149 gene
polymorphism and nasopharyngeal carcinoma. Biomed Rep. 1:599–603.
2013.
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Yan L, Zhang W, Wang H, Chen W, Hu N
and Ou H: miR-21 inhibitor suppresses proliferation and migration
of nasopharyngeal carcinoma cells through down-regulation of BCL2
expression. Int J Clin Exp Pathol. 7:3478–3487. 2014.PubMed/NCBI
|
|
13
|
Zhang Z, Ma J, Luan G, Kang L, Su Y, He Y
and Luan F: MiR-506 suppresses tumor proliferation and invasion by
targeting FOXQ1 in nasopharyngeal carcinoma. PLoS One.
10:e01228512015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang W, Lan X, Li D, Li T and Lu S:
MiR-223 targeting MAFB suppresses proliferation and migration of
nasopharyngeal carcinoma cells. BMC Cancer. 15:4612015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qi X, Li J, Zhou C, Lv C and Tian M:
MiR-142-3p suppresses SOCS6 expression and promotes cell
proliferation in nasopharyngeal carcinoma. Cell Physiol Biochem.
36:1743–1752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Q, Zhai YX, Liu HQ, Shi YA and Li XB:
MicroRNA-491-5p suppresses cervical cancer cell growth by targeting
hTERT. Oncol Rep. 34:979–986. 2015.PubMed/NCBI
|
|
17
|
Zeng H, Yiling C, Wenting Y, XuQun H,
ChuanYi Z and Hui L: miR-491-5p functions as a tumor suppressor by
targeting JMJD2B in ERα-positive breast cancer. FEBS Lett.
589:812–821. 2015. View Article : Google Scholar
|
|
18
|
Huang WC, Chan SH, Jang TH, Chang JW, Ko
YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, et al:
miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral
squamous cell carcinoma invasion and metastasis. Cancer Res.
74:751–764. 2014. View Article : Google Scholar
|
|
19
|
Denoyelle C, Lambert B, Meryet-Figuière M,
Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis MH,
Gauduchon P, et al: miR-491-5p-induced apoptosis in ovarian
carcinoma depends on the direct inhibition of both
BCL-XL and EGFR leading to BIM activation. Cell Death
Dis. 5:e14452014. View Article : Google Scholar
|
|
20
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baron M: An overview of the Notch
signalling pathway. Semin Cell Dev Biol. 14:113–119. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fre S, Huyghe M, Mourikis P, Robine S,
Louvard D and Artavanis-Tsakonas S: Notch signals control the fate
of immature progenitor cells in the intestine. Nature. 435:964–968.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu J, Luo H, Liu X, Peng Y, Zhang B, Wang
L, Xu X, Peng X, Li G, Tian W, et al: miR-9 targets CXCR4 and
functions as a potential tumor suppressor in nasopharyngeal
carcinoma. Carcinogenesis. 35:554–563. 2014. View Article : Google Scholar
|
|
26
|
Kang H, Jeong JY, Song JY, Kim TH, Kim G,
Huh JH, Kwon AY, Jung SG and An HJ: Notch3-specific inhibition
using siRNA knockdown or GSI sensitizes paclitaxel-resistant
ovarian cancer cells. Mol Carcinog. Jul 24–2015.Epub ahead of
print. View
Article : Google Scholar
|
|
27
|
Jaskula-Sztul R, Eide J, Tesfazghi S,
Dammalapati A, Harrison AD, Yu XM, Scheinebeck C, Winston-McPherson
G, Kupcho KR, Robers MB, et al: Tumor-suppressor role of Notch3 in
medullary thyroid carcinoma revealed by genetic and pharmacological
induction. Mol Cancer Ther. 14:499–512. 2015. View Article : Google Scholar :
|
|
28
|
Alqudah MA, Agarwal S, Al-Keilani MS,
Sibenaller ZA, Ryken TC and Assem M: NOTCH3 is a prognostic factor
that promotes glioma cell proliferation, migration and invasion via
activation of CCND1 and EGFR. PLoS One. 8:e772992013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang XW, Xi XQ, Wu J, Wan YY, Hui HX and
Cao XF: MicroRNA-206 attenuates tumor proliferation and migration
involving the downregulation of NOTCH3 in colorectal cancer. Oncol
Rep. 33:1402–1410. 2015.PubMed/NCBI
|
|
30
|
Furukawa S, Kawasaki Y, Miyamoto M,
Hiyoshi M, Kitayama J and Akiyama T: The miR-1-NOTCH3-Asef pathway
is important for colorectal tumor cell migration. PLoS One.
8:e806092013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Man CH, Wei-Man Lun S, Wai-Ying Hui J, To
KF, Choy KW, Wing-Hung Chan A, Chow C, Tin-Yun Chung G, Tsao SW,
Tak-Chun Yip T, et al: Inhibition of NOTCH3 signalling
significantly enhances sensitivity to cisplatin in EBV-associated
nasopharyngeal carcinoma. J Pathol. 226:471–481. 2012. View Article : Google Scholar
|
